Company news
Personalis, Inc. news in 2021
Personalis, Inc.'s news releases, calls and decks from 2021, newest first.
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
December 27, 2021
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
December 15, 2021
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
November 17, 2021
Personalis Named to Inc.'s 2021 Best-Led Companies List
November 11, 2021
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 10, 2021
Personalis Reports Third Quarter 2021 Financial Results
November 3, 2021
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
November 1, 2021
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
October 25, 2021
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
October 25, 2021
Personalis to Announce Third Quarter Financial Results on November 4, 2021
October 20, 2021
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
October 12, 2021
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing
October 11, 2021
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
September 17, 2021
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
August 25, 2021
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development
August 24, 2021
Personalis Reports Second Quarter 2021 Financial Results
August 3, 2021
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
August 2, 2021
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
August 1, 2021
Personalis to Announce Second Quarter Financial Results on August 4, 2021
July 20, 2021
Personalis Announces NeXT Level Biomarkers Symposium
June 21, 2021
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
June 1, 2021
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 17, 2021
Personalis, Inc. to Present at Biomarkers Week Online 2021
May 16, 2021
Personalis Reports First Quarter 2021 Financial Results
May 4, 2021
Personalis to Present at the 2021 Bank of America Healthcare Conference
April 28, 2021
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
April 20, 2021
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
April 7, 2021
Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development
March 28, 2021
Personalis Announces Changes to its Board of Directors
March 7, 2021
Personalis Reports Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021
CORRECTING and REPLACING Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021
February 21, 2021
Natera and Personalis Partner for Personalized Monitoring in Oncology
February 16, 2021
Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021
February 10, 2021
Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer
February 7, 2021
Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 3, 2021
Personalis Announces Pricing of Public Offering of Common Stock
January 25, 2021
Personalis Announces Launch of Public Offering of Common Stock
January 25, 2021
Personalis Reports Preliminary Fourth Quarter 2020 Revenue
January 10, 2021